imipramine has been researched along with Suicidal Ideation in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Suicidal Ideation: A risk factor for suicide attempts and completions, it is the most common of all suicidal behavior, but only a minority of ideators engage in overt self-harm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LUBY, ED | 1 |
| DOMINO, EF | 1 |
1 other study available for imipramine and Suicidal Ideation
| Article | Year |
|---|---|
Toxicity from large doses of imipramine and an MAO inhibitor in suicidal intent.
Topics: Cyclopropanes; Imipramine; Monoamine Oxidase Inhibitors; Oxidoreductases; Psychopharmacology; Suicid | 1961 |